Noninvasive system for evaluating allergen-induced nasal hypersensitivity in murine allergic rhinitis.
Until now there has been no method for physiologically evaluating nasal hypersensitivity in mice. Enhanced pause (Penh) has been used as an indicator that reflects changes in the lower airway. Recently, however, there is disagreement regarding the significance of the Penh system; this is because Penh is not essentially a physiological parameter, and it might not necessarily represent a change in the lower respiratory tract. The purpose of the present study is to investigate whether Penh could be applicable for analyzing nasal hypersensitivity in mice. BALB/c mice were sensitized with ovalbumin (OVA) through a combination of intraperitoneal injection and daily intranasal challenge in an awake condition. Penh was measured at each time point during sensitization, or a serial change in Penh value was followed after the final nasal challenge and the effect of treatment was assessed. Following sensitization and nasal challenge, the Penh value gradually increased and showed a significant difference on day 14. Changes in IgE, eosinophil infiltration into nasal mucosa, and OVA-induced symptoms all strongly correlated with the increase in Penh. On day 19, after OVA nasal provocation, Penh gradually increased and reached maximal values 25 min after the challenge. Pretreatment with dexamethasone or a histamine H1 blocker significantly suppressed this increase in Penh. We confirmed that intranasal OVA challenge did not induce bronchoconstriction by measuring airway resistance and bronchoalveolar lavage fluid, and through histological examination. These results clearly demonstrate that Penh could be a useful noninvasive indicator for studying nasal hypersensitivity.
Nakaya
Muneo
M
Department of Otolaryngology, Faculty of Medicine, University of Tokyo, Tokyo, Japan. muneo@interlink.or.jp
Dohi
Makoto
M
Okunishi
Katsuhide
K
Nakagome
Kazuyuki
K
Tanaka
Ryoichi
R
Imamura
Mitsuru
M
Baba
Shintaro
S
Takeuchi
Naonobu
N
Yamamoto
Kazuhiko
K
Kaga
Kimitaka
K
D000403:Airway Resistance / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D004804:Eosinophils / Q000502:physiology; D004837:Epinephrine / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D006969:Hypersensitivity, Immediate / Q000503:physiopathology*; D007114:Immunization; D007073:Immunoglobulin E / Q000097:blood; D008168:Lung / Q000473:pathology / Q000503:physiopathology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009296:Nasal Cavity / Q000503:physiopathology; D009297:Nasal Mucosa / Q000473:pathology / Q000503:physiopathology; D010047:Ovalbumin / Q000494:pharmacology; D012221:Rhinitis, Allergic, Perennial / Q000503:physiopathology*
D007073:Immunoglobulin E; D006632:Histamine; D010047:Ovalbumin; D004837:Epinephrine